These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

535 related articles for article (PubMed ID: 11366076)

  • 1. Low-dose cyclosporin: government trial recruiting, CD4 count over 500.
    AIDS Treat News; 1998 Dec; (No 308):5-6. PubMed ID: 11366076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. San Franscisco area: important cyclosporin study recruiting.
    James JS
    AIDS Treat News; 1999 Mar; (No 315):8. PubMed ID: 11366562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New vaccine+HAART treatment trial enrolling at NIH. National Institutes of Health.
    James JS
    AIDS Treat News; 1998 Aug; (No 300):3-4. PubMed ID: 11365687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporin A provides no sustained immunologic benefit to persons with chronic HIV-1 infection starting suppressive antiretroviral therapy: results of a randomized, controlled trial of the AIDS Clinical Trials Group A5138.
    Lederman MM; Smeaton L; Smith KY; Rodriguez B; Pu M; Wang H; Sevin A; Tebas P; Sieg SF; Medvik K; Margolis DM; Pollard R; Ertl HC; Valdez H
    J Infect Dis; 2006 Dec; 194(12):1677-85. PubMed ID: 17109339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-2 without antiretroviral therapy, trial near Wash. D.C.
    AIDS Treat News; 1998 Mar; (No 290):7. PubMed ID: 11365122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral activity of low-dose alovudine in antiretroviral-experienced patients: results from a 4-week randomized, double-blind, placebo-controlled dose-ranging trial.
    Ghosn J; Quinson AM; Sabo N; Cotte L; Piketty C; Dorléacq N; Bravo ML; Mayers D; Harmenberg J; Mårdh G; Valdez H; Katlama C
    HIV Med; 2007 Apr; 8(3):142-7. PubMed ID: 17461857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New immune-based treatment approach: trial recruiting in San Francisco.
    James JS
    AIDS Treat News; 2001 Feb; (360):3-4. PubMed ID: 12173566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-2 clinical trials.
    Newsline People AIDS Coalit N Y; 1998 Sep; ():58. PubMed ID: 11367495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-20: new trial enrolling, 9 U.S. cities.
    James JS
    AIDS Treat News; 1998 Aug; (No 300):1-3. PubMed ID: 11365686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AIDS diarrhea: phase III trial recruiting in over 30 U.S. sites.
    AIDS Treat News; 1998 Jul; (No 299):8. PubMed ID: 11365601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guidelines for kidney transplantation in patients with HIV disease.
    Bhagani S; Sweny P; Brook G;
    HIV Med; 2006 Apr; 7(3):133-9. PubMed ID: 16494626
    [No Abstract]   [Full Text] [Related]  

  • 12. Pacing program for 3TC.
    Posit Aware; 1995; ():5. PubMed ID: 11362665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical study on treatment of HIV infected persons based on viral load detection and CD4+ T lymphocyte counting].
    Lin X; Xu L; Feng Y; Li J; Pei L; Shen T; Shao Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Sep; 16(3):211-4. PubMed ID: 12665921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Placebo-controlled trial of cyclosporin-A in HIV-1 disease: implications for solid organ transplantation.
    Calabrese LH; Lederman MM; Spritzler J; Coombs RW; Fox L; Schock B; Yen-Lieberman B; Johnson R; Mildvan D; Parekh N;
    J Acquir Immune Defic Syndr; 2002 Apr; 29(4):356-62. PubMed ID: 11917239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicentre study to determine the efficacy and tolerability of a combination of nelfinavir (VIRACEPT), zalcitabine (HIVID) and zidovudine in the treatment of HIV infected Nigerian patients.
    Idoko JA; Akinsete L; Abalaka AD; Keshinro LB; Dutse L; Onyenekwe B; Lhekwaba A; Njoku OS; Kehinde MO; Wambebe CO
    West Afr J Med; 2002; 21(2):83-6. PubMed ID: 12403023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective trial of structured treatment interruptions in human immunodeficiency virus infection.
    Fagard C; Oxenius A; Günthard H; Garcia F; Le Braz M; Mestre G; Battegay M; Furrer H; Vernazza P; Bernasconi E; Telenti A; Weber R; Leduc D; Yerly S; Price D; Dawson SJ; Klimkait T; Perneger TV; McLean A; Clotet B; Gatell JM; Perrin L; Plana M; Phillips R; Hirschel B;
    Arch Intern Med; 2003 May; 163(10):1220-6. PubMed ID: 12767960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Women, HIV & viral load.
    Denison R
    WORLD; 1999 Apr; (No 96):4-5. PubMed ID: 11366945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term clinical, immunologic and virologic impact of glucocorticoids on the chronic phase of HIV infection.
    Andrieu JM; Lu W
    BMC Med; 2004 May; 2():17. PubMed ID: 15128452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interruption of antiretroviral treatment in HIV-infected patients with preserved immune function is associated with a low rate of clinical progression: a prospective study by AIDS Clinical Trials Group 5170.
    Skiest DJ; Su Z; Havlir DV; Robertson KR; Coombs RW; Cain P; Peterson T; Krambrink A; Jahed N; McMahon D; Margolis DM;
    J Infect Dis; 2007 May; 195(10):1426-36. PubMed ID: 17436222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients sought for ACTU studies that will help answer questions about drugs.
    Fac Notes (New Orleans La); 1998; 10(6):6. PubMed ID: 11366145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.